Active substance
Results for the substance ponesimod
2 results
About this active substance
Ponesimod is a medication used for the treatment of relapsing multiple sclerosis, an autoimmune disease that affects the central nervous system.
It belongs to the class of sphingosine-1-phosphate (S1P) receptor modulators, which work by reducing the migration of lymphocytes into the central nervous system, thereby decreasing inflammation and nerve damage.
Ponesimod is administered as oral tablets, usually once daily, with the dose gradually increased to minimize the risk of side effects.
The medication helps reduce the frequency of relapses and slow the progression of disability associated with multiple sclerosis.
Common side effects include headaches, fatigue, nausea, and respiratory infections.
In rare cases, more serious adverse effects may occur, such as bradycardia (slow heart rate), macular edema, or elevated liver enzyme levels.
It is important for patients to undergo blood tests and ophthalmologic evaluations before starting treatment with ponesimod.
Additionally, patients should inform their doctor about any other medications they are taking, as ponesimod may interact with other treatments.
It belongs to the class of sphingosine-1-phosphate (S1P) receptor modulators, which work by reducing the migration of lymphocytes into the central nervous system, thereby decreasing inflammation and nerve damage.
Ponesimod is administered as oral tablets, usually once daily, with the dose gradually increased to minimize the risk of side effects.
The medication helps reduce the frequency of relapses and slow the progression of disability associated with multiple sclerosis.
Common side effects include headaches, fatigue, nausea, and respiratory infections.
In rare cases, more serious adverse effects may occur, such as bradycardia (slow heart rate), macular edema, or elevated liver enzyme levels.
It is important for patients to undergo blood tests and ophthalmologic evaluations before starting treatment with ponesimod.
Additionally, patients should inform their doctor about any other medications they are taking, as ponesimod may interact with other treatments.